Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions

Reuters

05-24

Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions

Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537163348"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537163348\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537163348?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-24 07:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537163348","market":"nz","top_or_hot":-1,"title":"Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAchieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-24 07:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACHV","symbol_name":"Achieve Life Sciences, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL9dfVhl:1","article_id":"2537163348","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537163348","pubTimestamp":1748044795,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application  for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACHV":"Achieve Life Sciences, Inc.","BK4139":"生物科技"},"translate_title":"Achieve Life Sciences Inc.推出关于通过戒烟解决方案改变公共卫生的演讲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACHV":0.9},"content_text":"Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions\n    \n\n        Achieve Life Sciences Inc. has presented its corporate presentation outlining its strategic approach to addressing nicotine dependence, a significant public health crisis. The company plans to file a New Drug Application (NDA) for smoking cessation in June 2025, with an anticipated launch in the third quarter of 2026. Additionally, Achieve is pursuing a vaping cessation indication under the FDA Breakthrough Therapy designation and Priority Review, contingent on financing. The presentation highlights the company's competitive advantage with a differentiated and well-tolerated product profile, alongside a favorable payor environment, including anticipated Affordable Care Act coverage. Achieve aims to leverage innovative, data-driven solutions to drive product adoption and future growth. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}